Renaissance Technologies’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,385
| Closed | -$117K | – | 4014 |
|
|
2025
Q1 | $117K | Buy |
26,385
+14,825
| +128% | +$63.6K | ﹤0.01% | 3173 |
|
|
2024
Q4 | $45.9K | Buy |
+11,560
| New | +$46.8K | ﹤0.01% | 3402 |
|
|
2024
Q1 | – | Sell |
-23,432
| Closed | -$84K | – | 4185 |
|
|
2023
Q4 | $84K | Buy |
23,432
+19,674
| +524% | +$82.7K | ﹤0.01% | 3348 |
|
|
2023
Q3 | $22K | Buy |
3,758
+743
| +25% | +$4.82K | ﹤0.01% | 3516 |
|
|
2023
Q2 | $24K | Sell |
3,015
-1,670
| -36% | -$15.4K | ﹤0.01% | 3743 |
|
|
2023
Q1 | $55K | Buy |
4,685
+78
| +2% | +$1.06K | ﹤0.01% | 3642 |
|
|
2022
Q4 | $55K | Buy |
4,607
+1,082
| +31% | +$15.4K | ﹤0.01% | 3780 |
|
|
2022
Q3 | $79K | Sell |
3,525
-1,989
| -36% | -$54.6K | ﹤0.01% | 3658 |
|
|
2022
Q2 | $162K | Buy |
5,514
+1,748
| +46% | +$52.2K | ﹤0.01% | 3726 |
|
|
2022
Q1 | $125K | Sell |
3,766
-14,326
| -79% | -$510K | ﹤0.01% | 3757 |
|
|
2021
Q4 | $727K | Buy |
18,092
+9,717
| +116% | +$575K | ﹤0.01% | 2885 |
|
|
2021
Q3 | $679K | Sell |
8,375
-10,375
| -55% | -$928K | ﹤0.01% | 2749 |
|
|
2021
Q2 | $512K | Buy |
18,750
+6,542
| +54% | +$168K | ﹤0.01% | 2956 |
|
|
2021
Q1 | $333K | Buy |
+12,208
| New | +$370K | ﹤0.01% | 3027 |
|
|
2020
Q1 | – | Sell |
-7,172
| Closed | -$247K | – | 3897 |
|
|
2019
Q4 | $247K | Sell |
7,172
-161
| -2% | -$4.66K | ﹤0.01% | 3132 |
|
|
2019
Q3 | $188K | Buy |
7,333
+613
| +9% | +$18.5K | ﹤0.01% | 3165 |
|
|
2019
Q2 | $220K | Buy |
6,720
+1,857
| +38% | +$108K | ﹤0.01% | 3281 |
|
|
2019
Q1 | $428K | Buy |
4,863
+1,044
| +27% | +$86.6K | ﹤0.01% | 2981 |
|
|
2018
Q4 | $232K | Buy |
3,819
+1,149
| +43% | +$95.8K | ﹤0.01% | 3097 |
|
|
2018
Q3 | $284K | Buy |
2,670
+949
| +55% | +$96.3K | ﹤0.01% | 3037 |
|
|
2018
Q2 | $180K | Buy |
1,721
+282
| +20% | +$31.1K | ﹤0.01% | 3089 |
|
|
2018
Q1 | $162K | Sell |
1,439
-108
| -7% | -$13.5K | ﹤0.01% | 3214 |
|
|
2017
Q4 | $214K | Buy |
1,547
+627
| +68% | +$90.1K | ﹤0.01% | 3114 |
|
|
2017
Q3 | $150K | Buy |
920
+459
| +100% | +$75.6K | ﹤0.01% | 3049 |
|
|
2017
Q2 | $99K | Buy |
461
+270
| +141% | +$83.8K | ﹤0.01% | 3086 |
|
|
2017
Q1 | $76K | Buy |
191
+45
| +31% | +$19.4K | ﹤0.01% | 3108 |
|
|
2016
Q4 | $69K | Buy |
146
+48
| +49% | +$35.9K | ﹤0.01% | 3138 |
|
|
2016
Q3 | $98K | Buy |
98
+14
| +17% | +$14K | ﹤0.01% | 3182 |
|
|
2016
Q2 | $89K | Sell |
84
-6
| -7% | -$6.83K | ﹤0.01% | 3179 |
|
|
2016
Q1 | $106K | Buy |
90
+33
| +58% | +$34.2K | ﹤0.01% | 3205 |
|
|
2015
Q4 | $73K | Buy |
57
+8
| +16% | +$14.2K | ﹤0.01% | 3142 |
|
|
2015
Q3 | $111K | Buy |
49
+19
| +63% | +$43.1K | ﹤0.01% | 2998 |
|
|
2015
Q2 | $69K | Buy |
30
+22
| +275% | +$66.1K | ﹤0.01% | 3131 |
|
|
2015
Q1 | $34K | Buy |
+8
| New | +$35.2K | ﹤0.01% | 3099 |
|
|
2014
Q1 | – | Sell |
-31
| Closed | -$231K | – | 3059 |
|
|
2013
Q4 | $231K | Sell |
31
-3
| -9% | -$16.9K | ﹤0.01% | 2578 |
|
|
2013
Q3 | $145K | Sell |
34
-2
| -6% | -$8.84K | ﹤0.01% | 2641 |
|
|
2013
Q2 | $183K | Buy |
+36
| New | +$191K | ﹤0.01% | 2537 |
|
Renaissance Technologies's NURO Position: Q2 2025 in Review
Renaissance Technologies sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q2 2025, closing a stake of 26,385 shares — an estimated $117K sold.
Renaissance Technologies first reported a position in NURO in Q2 2013 and held it in 37 quarters. The position peaked at $727K in Q4 2021. 0 funds tracked by Wall St. Rank hold NURO as of Q2 2025.
- Renaissance Technologies reported no remaining NeuroMetrix, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- Renaissance Technologies sold 26,385 NeuroMetrix, Inc. Common Stock shares in Q2 2025, an estimated $117K.
- Renaissance Technologies first reported a position in NeuroMetrix, Inc. Common Stock in Q2 2013 and held it in 37 quarters.
- Renaissance Technologies's NeuroMetrix, Inc. Common Stock position peaked at $727K in Q4 2021.
- 0 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q2 2025.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.